{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:03:52Z","timestamp":1791187432993,"version":"4.1.0"},"reference-count":40,"publisher":"EDP Sciences","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1051\/medsci\/20102611969","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T19:04:33Z","timestamp":1299006273000},"page":"969-975","source":"Crossref","is-referenced-by-count":4,"title":["La fi\u00e8vre typho\u00efde n\u2019est plus aussi simple \u00e0 soigner"],"prefix":"10.1051","volume":"26","author":[{"given":"Fran\u00e7ois-Xavier","family":"Weill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2010,11,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Roumagnac P, Weill FX, Dolecek C,et al. Evolutionary history ofSalmonellaTyphi.Science2006 ; 314 : 1301-4.","DOI":"10.1126\/science.1134933"},{"key":"R2","unstructured":"Delmas G, Haeghebaert S, de Valk J, Weill FX. Les fi\u00e8vres typho\u00efdes et paratypho\u00efdes en France de 2001 \u00e0 2003. Surveillance nationale des maladies infectieuses. URL : http:\/\/www.invs.sante.fr\/publications\/2005\/snmi\/pdf\/fievres_typhoides.pdf ."},{"key":"R3","unstructured":"Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever.Bull World Health Organ2004 ; 82 : 346-53."},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Anderson ES. The problem and implications of chloramphenicol resistance in the typhoid bacillus.J Hyg (Lond)1975 ; 74 : 289-99.","DOI":"10.1017\/S0022172400024360"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Anderson ES, Smith HR. Chloramphenicol resistance in the typhoid bacillus.Br Med J1972 ; 3 : 329-31.","DOI":"10.1136\/bmj.3.5822.329"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Olarte J, Galindo E.Salmonella typhiresistant to chloramphenicol, ampicillin, and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico.Antimicrob Agents Chemother1973 ; 4 : 597-601.","DOI":"10.1128\/AAC.4.6.597"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Datta N, Olarte J. R factors in strains ofSalmonella typhiandShigella dysenteriae1 isolated during epidemics in Mexico: classification by compatibility.Antimicrob Agents Chemother1974 ; 5 : 310-7.","DOI":"10.1128\/AAC.5.3.310"},{"key":"R8","unstructured":"Meyruey MH, Goudineau JA, Berger P,et al. Actualit\u00e9 de la fi\u00e8vre typho\u00efde au Sud Vietnam.Rev Epidemiol Med Soc Sant\u00e9 publique1975 ; 23 : 345-58."},{"key":"R9","unstructured":"Chabbert YA, Gerbaud GR. Surveillance \u00e9pid\u00e9miologique des plasmides responsables de la r\u00e9sistance au chloramph\u00e9nicol deSalmonella typhi. Ann Microbiol (Paris)1974 ; 125A : 153-66."},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Goldstein FW, Chumpitaz JC, Guevara JM,et al. Plasmid-mediated resistance to multiple antibiotics inSalmonellatyphi.J Infect Dis1986 ; 153 : 261-6.","DOI":"10.1093\/infdis\/153.2.261"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Wain J, Kidgell C. The emergence of multidrug resistance to antimicrobial agents for the treatment of typhoid fever.Trans R Soc Trop Med Hyg2004 ; 98 : 423-30.","DOI":"10.1016\/j.trstmh.2003.10.015"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Le TA, Lejay-Collin M, Grimont PA,et al. Endemic, epidemic clone ofSalmonella entericaserovar typhi harboring a single multidrug-resistant plasmid in Vietnam between 1995 and 2002.J Clin Microbiol2004 ; 42 : 3094-9.","DOI":"10.1128\/JCM.42.7.3094-3099.2004"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Threlfall EJ, Ward LR. Decreased susceptibility to ciprofloxacin inSalmonella entericaserotype Typhi, United Kingdom.Emerg Infect Dis2001 ; 7 : 448-50.","DOI":"10.3201\/eid0703.010315"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Le TA, Fabre L, Roumagnac P,et al. Clonal expansion and microevolution of quinolone resistantSalmonella entericaserotype Typhi in Vietnam from 1996 to 2004.J Clin Microbiol2007 ; 45 : 3485-92.","DOI":"10.1128\/JCM.00948-07"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Wain J, Hoa NT, Chinh NT,et al. Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment.Clin Infect Dis1997 ; 25 : 1404-10.","DOI":"10.1086\/516128"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Crump JA, Barrett TJ, Nelson JT, Angulo FJ. Reevaluating fluoroquinolone breakpoints forSalmonella entericaserotype Typhi and for non-Typhisalmonellae. Clin Infect Dis2003 ; 37 : 75-81.","DOI":"10.1086\/375602"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Aarestrup FM, Wiuff C, M\u00f8lbak K, Threlfall EJ. Is it time to change fluoroquinolone breakpoints forSalmonellaspp.?Antimicrob Agents Chemother2003 ; 47 : 827-9.","DOI":"10.1128\/AAC.47.2.827-829.2003"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Crump JA, Kretsinger K, Gay K,et al. Clinical response and outcome of infection withSalmonella entericaserotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.Antimicrob Agents Chemother2008 ; 52 : 1278-84.","DOI":"10.1128\/AAC.01509-07"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Booker BM, Smith PF, Forrest A,et al. Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints forSalmonella entericaserotype typhi.Antimicrob Agents Chemother2005 ; 49 : 1775-81.","DOI":"10.1128\/AAC.49.5.1775-1781.2005"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Smith MD, Duong NM, Hoa NT,et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever.Antimicrob Agents Chemother1994 ; 38 : 1716-20.","DOI":"10.1128\/AAC.38.8.1716"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Tran TH, Bethell DB, Nguyen TT,et al. Short course of ofloxacin for treatment of multidrug- resistant typhoid.C!in Infect Dis1995 ; 20 : 917-23.","DOI":"10.1093\/clinids\/20.4.917"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Nguyen TC, Solomon T, Mai XT,et al. Short courses of ofloxacin for the treatment of enteric fever.Trans R Soc Trop Med Hyg1997 ; 91 : 347-9.","DOI":"10.1016\/S0035-9203(97)90102-4"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Weill FX, Tran HH, Roumagnac P,et al. Clonal reconquest of antibiotic-susceptibleSalmonella entericaserotype Typhi in Son La Province, Vietnam.AmJTrop Med Hyg2007 ; 76 : 1174-81.","DOI":"10.4269\/ajtmh.2007.76.1174"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Cooke FJ, Day M, Wain J,et al. Cases of typhoid fever imported into England, Scotland and Wales (2000-2003).Trans R Soc Trop Med Hyg2007 ; 101 : 398-404.","DOI":"10.1016\/j.trstmh.2006.07.005"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Lynch MF, Blanton EM, Bulens S,et al. Typhoid fever in the United States, 1999-2006.JAMA2009 ; 302 : 859-65.","DOI":"10.1001\/jama.2009.1229"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Chau TT, Campbell JI, Galindo CM,et al. Antimicrobial drug resistance ofSalmonella entericaserovar Typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.Antimicrob Agents Chemother2007 ; 51 : 4315-23.","DOI":"10.1128\/AAC.00294-07"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Gaborieau V, Weill FX, Marchou B.Salmonella entericaserovar Typhi de sensibilit\u00e9 diminu\u00e9e \u00e0 la ciprofloxacine.Med Mal Infect2010 (sous presse).","DOI":"10.1016\/j.medmal.2010.06.009"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Song Y, Roumagnac P, Weill FX,et al. A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility inSalmonella entericaserovars Typhi and Paratyphi A.J Antimicrob Chemother2010 ; 65 : 1631-41.","DOI":"10.1093\/jac\/dkq175"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Parry CM, Ho VA, Phuong le T,et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever.Antimicrob Agents Chemother2007 ; 51 : 819-25.","DOI":"10.1128\/AAC.00447-06"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Pandit A, Arjyal A, Day JN,et al. An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever.PLoS One2007 ; 2 : e542.","DOI":"10.1371\/journal.pone.0000542"},{"key":"R31","unstructured":"Dolecek C, Tran TP, Nguyen NR,et al. A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam.PLoS One2008 ; 3 : e2188."},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Dimitrov T, Dashti AA, Albaksami O,et al. Ciprofloxacin-resistantSalmonella entericaserovar Typhi from Kuwait with novel mutations ingyrAandparCgenes.J Clin Microbiol2009 ; 47 : 208-11.","DOI":"10.1128\/JCM.01161-08"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Keddy KH, Smith AM, Sooka A,et al. Fluoroquinolone-resistant typhoid, South Africa.Emerg Infect Dis2010 ; 16 : 879-80.","DOI":"10.3201\/eid1605.091917"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Rotimi VO, Jamal W, Pal T,et al. Emergence of CTX-M-15 type extended-spectrum betalactamase-producingSalmonellaspp. in Kuwait and the United Arab Emirates.J Med Microbiol2008 ; 57 : 881-6.","DOI":"10.1099\/jmm.0.47509-0"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Al Naiemi N, Zwart B, Rijnsburger MC,et al. Extended-spectrum-beta-lactamase production in aSalmonella entericaserotype Typhi strain from the Philippines.J Clin Microbiol2008 ; 46 : 2794-5.","DOI":"10.1128\/JCM.00676-08"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Pfeifer Y, Matten J, Rabsch W.Salmonella entericaserovar Typhi with CTX-M beta-lactamase, Germany.Emerg Infect Dis2009 ; 15 : 1533-5.","DOI":"10.3201\/eid1509.090567"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"Capoor MR, Rawat D, Nair D,et al. In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistantSalmonellacausing enteric fever.J Med Microbiol2007 ; 56 : 1490-4.","DOI":"10.1099\/jmm.0.47353-0"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Threlfall EJ, de Pinna E, Day M,et al. Alternatives to ciprofloxacin use for enteric fever, United Kingdom.Emerg Infect Dis2008 ; 14 : 860-1.","DOI":"10.3201\/eid1405.071184"},{"key":"R39","doi-asserted-by":"crossref","unstructured":"Boumghar-Bourtchai L, Mariani-Kurkdjian P, Bingen E,et al. Macrolide-resistantShigella sonnei. Emerg Infect Dis2008 ; 14 : 1297-9.","DOI":"10.3201\/eid1408.080147"},{"key":"R40","doi-asserted-by":"crossref","unstructured":"Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever.BMJ2006 ; 333 : 78-82.","DOI":"10.1136\/bmj.333.7558.78"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20102611969\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T22:24:11Z","timestamp":1560032651000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20102611969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":40,"journal-issue":{"issue":"11"},"alternative-id":["medsci20102611p969"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/20102611969","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}